These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2157882)

  • 1. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
    J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
    Watanabe SM; Rosenberg NE; Witte ON
    J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
    Shore SK; Bogart SL; Reddy EP
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
    Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
    J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two families of abl-related transcripts in human haematopoietic cells differing in their homology to v-abl.
    Savin KW; Adams FC; Devereux LM; Jose DG; de Kretser TA
    Mol Biol Med; 1984 Dec; 2(6):397-409. PubMed ID: 6085879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis.
    Engelman A; Rosenberg N
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8021-5. PubMed ID: 2825174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.
    Mathey-Prevot B; Nabel G; Palacios R; Baltimore D
    Mol Cell Biol; 1986 Nov; 6(11):4133-5. PubMed ID: 3025637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.
    Parmar K; Huebner RC; Rosenberg N
    J Virol; 1991 Dec; 65(12):6478-85. PubMed ID: 1942244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
    Engelman A; Rosenberg N
    Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts.
    Rohrschneider LR; Najita LM
    J Virol; 1984 Aug; 51(2):547-52. PubMed ID: 6086963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.
    Prywes R; Foulkes JG; Baltimore D
    J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.
    Rosenberg NE; Clark DR; Witte ON
    J Virol; 1980 Dec; 36(3):766-74. PubMed ID: 6257926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abelson murine leukemia virus: structural requirements for transforming gene function.
    Srinivasan A; Dunn CY; Yuasa Y; Devare SG; Reddy EP; Aaronson SA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5508-12. PubMed ID: 6291048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.
    Wang JY; Baltimore D
    Mol Cell Biol; 1983 May; 3(5):773-9. PubMed ID: 6306446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.